Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT, Trimodal), Application (Oncology, Cardiology, Brain, Ophthalmology, Musculoskeletal), End User (Hospitals, Diagnostic Centers, Academia, Pharma-Biotech) - Global Forecast to 2024
出 版 商：MarketsandMarkets
出版日期：2019/09/13
頁 數：142頁
文件格式：PDF
價 格：
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
USD 10,000 (Hard copy)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
USD 10,000 (Hard copy)
“The global multimodal imaging market is projected to grow at a CAGR of 4.4% during the forecast period.”
Multimodal imaging includes PET/CT systems, SPECT/CT systems, PET/MR systems, OCT/Fundus Imaging systems, and other multimodal imaging systems. The global multimodal imaging market is projected to reach USD 2.9 billion by 2024 from USD 2.3 billion in 2019, at a CAGR of 4.4% from 2019 to 2024.
Growing applications of multimodal imaging systems, technological advancements in diagnostic imaging modalities, availability of funding for research, favorable reimbursement scenario, growing insurance coverage, and increasing R&D into radiotracers are some of the key factors driving the multimodal imaging market. However, the high cost of multimodal imaging systems, lack of infrastructure in emerging countries, and a dearth of trained professionals are expected to limit market growth to a certain extent.
“The PET/CT systems segment accounted for the largest share of the global multimodal imaging market in 2018.”
Based on technology, the multimodal imaging market is broadly segmented into PET/CT systems, PET/MR systems, SPECT/CT systems, OCT/Fundus Imaging systems, and other multimodal imaging systems (tri-modality systems such as SPECT/CT/PET, PET/CT + MR, and IVUS + NIRS systems, among others). The PET/CT systems segment accounted for the largest share of the multimodal imaging market in 2018. This can be attributed to the increasing demand for early and accurate cancer diagnosis, growing clinical evidence for the early detection of Alzheimer’s disease, increasing applications of PET/CT systems in cardiology, favorable reimbursement scenario, and the technological advancements in the field of PET/CT.
“The oncology segment accounted for the largest share of the multimodal imaging market in 2018.”
On the basis of application, the multimodal imaging market is segmented into brain & neurology, cardiology, oncology, ophthalmology, and other applications. The oncology segment accounted for the largest market share in 2018. This can be attributed to the expanding use of multimodal imaging systems in oncology diagnosis, increasing demand for the early & accurate diagnosis of cancer, and growing clinical evidence on the use of multimodal imaging in the diagnosis of novel cancer types.
“Europe accounted for the second-largest share of the global market in 2018.”
The multimodal imaging market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share of the market in 2018. Factors such as growing product approvals and rising public-private investments for developing multimodal imaging modalities for novel applications are the major factors driving market growth in Europe.
Breakdown of supply-side primary interviews:
‧ By Company Type: Tier 1 (30%), Tier 2 (32%), and Tier 3 (38%)
‧ By Designation: C-level (26%), Director-level (30%), and Others (44%)
‧ By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)
The major players operating in the multimodal imaging market are GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), United Imaging Healthcare Co., Ltd. (China), Canon Medical Systems Corporation (Japan), Mediso Medical Imaging Kft (Hungary), Neusoft Medical Systems Co., Ltd. (China), Spectrum Dynamics Medical (Switzerland), Infraredx, Inc. (Japan), Topcon Corporation (Japan), Carl Zeiss AG (Germany), and Heidelberg Engineering (Germany).
Research Coverage
This report studies the multimodal imaging market based on technology, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the multimodal imaging market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Multimodal imaging includes PET/CT systems, SPECT/CT systems, PET/MR systems, OCT/Fundus Imaging systems, and other multimodal imaging systems. The global multimodal imaging market is projected to reach USD 2.9 billion by 2024 from USD 2.3 billion in 2019, at a CAGR of 4.4% from 2019 to 2024.
Growing applications of multimodal imaging systems, technological advancements in diagnostic imaging modalities, availability of funding for research, favorable reimbursement scenario, growing insurance coverage, and increasing R&D into radiotracers are some of the key factors driving the multimodal imaging market. However, the high cost of multimodal imaging systems, lack of infrastructure in emerging countries, and a dearth of trained professionals are expected to limit market growth to a certain extent.
“The PET/CT systems segment accounted for the largest share of the global multimodal imaging market in 2018.”
Based on technology, the multimodal imaging market is broadly segmented into PET/CT systems, PET/MR systems, SPECT/CT systems, OCT/Fundus Imaging systems, and other multimodal imaging systems (tri-modality systems such as SPECT/CT/PET, PET/CT + MR, and IVUS + NIRS systems, among others). The PET/CT systems segment accounted for the largest share of the multimodal imaging market in 2018. This can be attributed to the increasing demand for early and accurate cancer diagnosis, growing clinical evidence for the early detection of Alzheimer’s disease, increasing applications of PET/CT systems in cardiology, favorable reimbursement scenario, and the technological advancements in the field of PET/CT.
“The oncology segment accounted for the largest share of the multimodal imaging market in 2018.”
On the basis of application, the multimodal imaging market is segmented into brain & neurology, cardiology, oncology, ophthalmology, and other applications. The oncology segment accounted for the largest market share in 2018. This can be attributed to the expanding use of multimodal imaging systems in oncology diagnosis, increasing demand for the early & accurate diagnosis of cancer, and growing clinical evidence on the use of multimodal imaging in the diagnosis of novel cancer types.
“Europe accounted for the second-largest share of the global market in 2018.”
The multimodal imaging market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share of the market in 2018. Factors such as growing product approvals and rising public-private investments for developing multimodal imaging modalities for novel applications are the major factors driving market growth in Europe.
Breakdown of supply-side primary interviews:
‧ By Company Type: Tier 1 (30%), Tier 2 (32%), and Tier 3 (38%)
‧ By Designation: C-level (26%), Director-level (30%), and Others (44%)
‧ By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)
The major players operating in the multimodal imaging market are GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), United Imaging Healthcare Co., Ltd. (China), Canon Medical Systems Corporation (Japan), Mediso Medical Imaging Kft (Hungary), Neusoft Medical Systems Co., Ltd. (China), Spectrum Dynamics Medical (Switzerland), Infraredx, Inc. (Japan), Topcon Corporation (Japan), Carl Zeiss AG (Germany), and Heidelberg Engineering (Germany).
Research Coverage
This report studies the multimodal imaging market based on technology, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the multimodal imaging market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKETS SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 20
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY RESEARCH 21
2.1.2.1 Key data from primary sources 22
2.2 MARKET SIZE ESTIMATION 23
2.2.1 PRODUCT-BASED MARKET ESTIMATION 24
2.2.2 PRIMARY RESEARCH VALIDATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 27
2.4.1 ASSUMPTIONS FOR THE STUDY 27
2.4.2 LIMITATIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33
4.1 MULTIMODAL IMAGING: MARKET OVERVIEW 33
4.2 GEOGRAPHIC ANALYSIS: MULTIMODAL IMAGING MARKET SHARE,
BY APPLICATION AND REGION, 2018 34
4.3 TECHNOLOGY ANALYSIS: MULTIMODAL IMAGING MARKET SIZE,
2019 VS 2024 (USD MILLION) 35
4.4 END-USER ANALYSIS: MULTIMODAL IMAGING MARKET SHARE, 2019 VS 2024 36
4.5 GEOGRAPHIC SNAPSHOT OF THE MULTIMODAL IMAGING MARKET 36
?
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Growing applications of multimodal imaging systems 38
5.2.1.2 Technological advancements in diagnostic imaging modalities 38
5.2.1.3 Availability of funding for research 40
5.2.2 RESTRAINTS 41
5.2.2.1 High cost of multimodal imaging systems 41
5.2.2.2 Lack of adequate healthcare infrastructure 41
5.2.3 OPPORTUNITIES 41
5.2.3.1 Availability of reimbursement and insurance coverage for scans 41
5.2.3.2 Increasing R&D into radiotracers 43
5.2.4 CHALLENGES 43
5.2.4.1 Dearth of trained professionals 43
6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY 44
6.1 INTRODUCTION 45
6.2 PET/CT SYSTEMS 45
6.2.1 PET/CT SYSTEMS HAVE ALMOST PRACTICALLY REPLACED STAND-
ALONE PET SYSTEMS ACROSS THE WORLD 45
6.2.2 PET/CT SYSTEMS MARKET SPLIT BY APPLICATION,
2017–2024 (USD MILLION) 47
6.2.3 PET/CT SYSTEMS MARKET SPLIT BY END USER, 2017–2024 (USD MILLION) 47
6.3 SPECT/CT SYSTEMS 48
6.3.1 IMPROVED RESOLUTION OF SPECT/CT SYSTEMS HAS PROVIDED A CLEAR ADVANTAGE OVER STAND-ALONE SPECT SYSTEMS 48
6.3.2 SPECT/CT SYSTEMS MARKET SPLIT BY APPLICATION,
2017–2024 (USD MILLION) 49
6.3.3 SPECT/CT SYSTEMS MARKET SPLIT BY END USER,
2017–2024 (USD MILLION) 49
6.4 PET/MR SYSTEMS 50
6.4.1 PET/MR SYSTEMS SHOWCASE INCREASING CLINICAL EVIDENCE WITH ENHANCED TISSUE CONTRAST 50
6.4.2 PET/MR SYSTEMS MARKET SPLIT BY APPLICATION,
2017–2024 (USD MILLION) 51
6.4.3 PET/MR SYSTEMS MARKET SPLIT BY END USER, 2017–2024 (USD MILLION) 52
6.5 OCT/FUNDUS IMAGING SYSTEMS 52
6.5.1 OCT/FUNDUS IMAGING SYSTEMS HAVE WIDE APPLICATIONS IN RETINAL DISEASE DIAGNOSIS 52
6.5.2 OCT/FUNDUS IMAGING SYSTEMS MARKET SPLIT BY APPLICATION,
2017–2024 (USD MILLION) 53
6.5.3 OCT/FUNDUS IMAGING SYSTEMS MARKET SPLIT BY END USER,
2017–2024 (USD MILLION) 54
?
6.6 OTHER MULTIMODAL IMAGING SYSTEMS 54
6.6.1 OTHER MULTIMODAL IMAGING SYSTEMS MARKET SPLIT BY APPLICATION, 2017–2024 (USD MILLION) 55
6.6.2 OTHER MULTIMODAL IMAGING SYSTEMS MARKET SPLIT BY END USER, 2017–2024 (USD MILLION) 56
7 MULTIMODAL IMAGING MARKET, BY APPLICATION 57
7.1 INTRODUCTION 58
7.2 ONCOLOGY 58
7.2.1 ONCOLOGY IS THE LARGEST APPLICATION SEGMENT OF THE MULTIMODAL IMAGING MARKET 58
7.3 OPHTHALMOLOGY 59
7.3.1 TECHNOLOGICAL INNOVATIONS IN OPHTHALMIC MULTIMODAL IMAGING SYSTEMS BY KEY MARKET PLAYERS TO SUPPORT MARKET GROWTH 59
7.4 CARDIOLOGY 61
7.4.1 INCREASING PREVALENCE OF CARDIAC CONDITIONS & INCREASING DEMAND FOR EARLY DISEASE DIAGNOSIS TO SUPPORT MARKET GROWTH 61
7.5 BRAIN & NEUROLOGY 62
7.5.1 INCREASING INCIDENCE OF BRAIN & NEUROLOGICAL DISORDERS TO PROPEL THE ADOPTION OF MULTIMODAL IMAGING SYSTEMS 62
7.6 OTHER APPLICATIONS 63
8 MULTIMODAL IMAGING MARKET, BY END USER 65
8.1 INTRODUCTION 66
8.2 HOSPITALS 66
8.2.1 LARGE HOSPITALS WITH NUCLEAR MEDICINE DEPARTMENTS HAVE BEEN EARLY ADOPTERS OF MULTIMODAL IMAGING SYSTEMS 66
8.3 DIAGNOSTIC IMAGING CENTERS 68
8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS IS CONTRIBUTING TO THE GROWTH OF THIS SEGMENT 68
8.4 OTHER END USERS 70
9 MULTIMODAL IMAGING MARKET, BY REGION 72
9.1 INTRODUCTION 73
9.2 NORTH AMERICA 73
9.2.1 US 77
9.2.1.1 The US dominates the North American multimodal imaging market 77
9.2.2 CANADA 78
9.2.2.1 Government budget cuts and long wait time for scans to hamper the market growth 78
9.3 EUROPE 79
9.3.1 GERMANY 82
9.3.1.1 Favorable reimbursement scenario in the country to support market growth 82
?
9.3.2 UK 83
9.3.2.1 Government initiatives and the increasing number of funding and research activities related to the use of multimodal imaging are driving market growth 83
9.3.3 FRANCE 84
9.3.3.1 France has the third-largest government expenditure on healthcare—a major factor driving market growth 84
9.3.4 REST OF EUROPE 85
9.4 ASIA PACIFIC 86
9.4.1 JAPAN 90
9.4.1.1 Large installation base of hybrid imaging systems – a major factor driving market growth 90
9.4.2 CHINA 91
9.4.2.1 China to witness the highest growth rate in the global multimodal imaging market during the forecast period 91
9.4.3 INDIA 92
9.4.3.1 Lack of reimbursement for diagnostic imaging procedures to hamper market growth 92
9.4.4 REST OF ASIA PACIFIC 93
9.5 LATIN AMERICA 93
9.5.1 BRAZIL 96
9.5.1.1 Brazil dominates the Latin American multimodal imaging market due to the high burden of cancer 96
9.5.2 MEXICO 97
9.5.2.1 Rising incidence of cancer to drive market growth in Mexico 97
9.5.3 REST OF LATIN AMERICA 97
9.6 MIDDLE EAST & AFRICA 98
9.6.1 IMPROVED HEALTHCARE INFRASTRUCTURE AND GROWING AWARENESS OF MULTIMODAL IMAGING ARE DRIVING MARKET GROWTH IN THE MEA 98
10 COMPETITIVE LANDSCAPE 101
10.1 INTRODUCTION 101
10.2 MARKET SHARE ANALYSIS, 2018 102
10.3 COMPETITIVE SITUATION AND TRENDS 102
10.4 COMPETITIVE LEADERSHIP MAPPING 104
10.5 VENDOR INCLUSION CRITERIA 105
10.6 VENDOR DIVE 105
10.6.1 VISIONARY LEADERS 105
10.6.2 INNOVATORS 105
10.6.3 DYNAMIC DIFFERENTIATORS 105
10.6.4 EMERGING PLAYERS 105
?
11 COMPANY PROFILES 107
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 CANON, INC. 107
11.2 GE HEALTHCARE 110
11.3 HEIDELBERG ENGINEERING 113
11.4 INFRAREDX, INC. (A PART OF NIPRO CORPORATION) 114
11.5 KONINKLIJKE PHILIPS N.V. 116
11.6 MEDISO MEDICAL IMAGING SYSTEMS KFT 118
11.7 NEUSOFT MEDICAL SYSTEMS CO., LTD 119
11.8 SIEMENS HEALTHINEERS 121
11.9 SPECTRUM DYNAMICS MEDICAL 124
11.10 TOPCON CORPORATION 125
11.11 UNITED IMAGING HEALTHCARE CO., LTD. 127
11.12 ZEISS GROUP 129
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 131
12.1 DISCUSSION GUIDE 131
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
12.3 AVAILABLE CUSTOMIZATIONS 140
12.4 RELATED REPORTS 140
12.5 AUTHOR DETAILS 141
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKETS SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 20
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY RESEARCH 21
2.1.2.1 Key data from primary sources 22
2.2 MARKET SIZE ESTIMATION 23
2.2.1 PRODUCT-BASED MARKET ESTIMATION 24
2.2.2 PRIMARY RESEARCH VALIDATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 27
2.4.1 ASSUMPTIONS FOR THE STUDY 27
2.4.2 LIMITATIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33
4.1 MULTIMODAL IMAGING: MARKET OVERVIEW 33
4.2 GEOGRAPHIC ANALYSIS: MULTIMODAL IMAGING MARKET SHARE,
BY APPLICATION AND REGION, 2018 34
4.3 TECHNOLOGY ANALYSIS: MULTIMODAL IMAGING MARKET SIZE,
2019 VS 2024 (USD MILLION) 35
4.4 END-USER ANALYSIS: MULTIMODAL IMAGING MARKET SHARE, 2019 VS 2024 36
4.5 GEOGRAPHIC SNAPSHOT OF THE MULTIMODAL IMAGING MARKET 36
?
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Growing applications of multimodal imaging systems 38
5.2.1.2 Technological advancements in diagnostic imaging modalities 38
5.2.1.3 Availability of funding for research 40
5.2.2 RESTRAINTS 41
5.2.2.1 High cost of multimodal imaging systems 41
5.2.2.2 Lack of adequate healthcare infrastructure 41
5.2.3 OPPORTUNITIES 41
5.2.3.1 Availability of reimbursement and insurance coverage for scans 41
5.2.3.2 Increasing R&D into radiotracers 43
5.2.4 CHALLENGES 43
5.2.4.1 Dearth of trained professionals 43
6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY 44
6.1 INTRODUCTION 45
6.2 PET/CT SYSTEMS 45
6.2.1 PET/CT SYSTEMS HAVE ALMOST PRACTICALLY REPLACED STAND-
ALONE PET SYSTEMS ACROSS THE WORLD 45
6.2.2 PET/CT SYSTEMS MARKET SPLIT BY APPLICATION,
2017–2024 (USD MILLION) 47
6.2.3 PET/CT SYSTEMS MARKET SPLIT BY END USER, 2017–2024 (USD MILLION) 47
6.3 SPECT/CT SYSTEMS 48
6.3.1 IMPROVED RESOLUTION OF SPECT/CT SYSTEMS HAS PROVIDED A CLEAR ADVANTAGE OVER STAND-ALONE SPECT SYSTEMS 48
6.3.2 SPECT/CT SYSTEMS MARKET SPLIT BY APPLICATION,
2017–2024 (USD MILLION) 49
6.3.3 SPECT/CT SYSTEMS MARKET SPLIT BY END USER,
2017–2024 (USD MILLION) 49
6.4 PET/MR SYSTEMS 50
6.4.1 PET/MR SYSTEMS SHOWCASE INCREASING CLINICAL EVIDENCE WITH ENHANCED TISSUE CONTRAST 50
6.4.2 PET/MR SYSTEMS MARKET SPLIT BY APPLICATION,
2017–2024 (USD MILLION) 51
6.4.3 PET/MR SYSTEMS MARKET SPLIT BY END USER, 2017–2024 (USD MILLION) 52
6.5 OCT/FUNDUS IMAGING SYSTEMS 52
6.5.1 OCT/FUNDUS IMAGING SYSTEMS HAVE WIDE APPLICATIONS IN RETINAL DISEASE DIAGNOSIS 52
6.5.2 OCT/FUNDUS IMAGING SYSTEMS MARKET SPLIT BY APPLICATION,
2017–2024 (USD MILLION) 53
6.5.3 OCT/FUNDUS IMAGING SYSTEMS MARKET SPLIT BY END USER,
2017–2024 (USD MILLION) 54
?
6.6 OTHER MULTIMODAL IMAGING SYSTEMS 54
6.6.1 OTHER MULTIMODAL IMAGING SYSTEMS MARKET SPLIT BY APPLICATION, 2017–2024 (USD MILLION) 55
6.6.2 OTHER MULTIMODAL IMAGING SYSTEMS MARKET SPLIT BY END USER, 2017–2024 (USD MILLION) 56
7 MULTIMODAL IMAGING MARKET, BY APPLICATION 57
7.1 INTRODUCTION 58
7.2 ONCOLOGY 58
7.2.1 ONCOLOGY IS THE LARGEST APPLICATION SEGMENT OF THE MULTIMODAL IMAGING MARKET 58
7.3 OPHTHALMOLOGY 59
7.3.1 TECHNOLOGICAL INNOVATIONS IN OPHTHALMIC MULTIMODAL IMAGING SYSTEMS BY KEY MARKET PLAYERS TO SUPPORT MARKET GROWTH 59
7.4 CARDIOLOGY 61
7.4.1 INCREASING PREVALENCE OF CARDIAC CONDITIONS & INCREASING DEMAND FOR EARLY DISEASE DIAGNOSIS TO SUPPORT MARKET GROWTH 61
7.5 BRAIN & NEUROLOGY 62
7.5.1 INCREASING INCIDENCE OF BRAIN & NEUROLOGICAL DISORDERS TO PROPEL THE ADOPTION OF MULTIMODAL IMAGING SYSTEMS 62
7.6 OTHER APPLICATIONS 63
8 MULTIMODAL IMAGING MARKET, BY END USER 65
8.1 INTRODUCTION 66
8.2 HOSPITALS 66
8.2.1 LARGE HOSPITALS WITH NUCLEAR MEDICINE DEPARTMENTS HAVE BEEN EARLY ADOPTERS OF MULTIMODAL IMAGING SYSTEMS 66
8.3 DIAGNOSTIC IMAGING CENTERS 68
8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS IS CONTRIBUTING TO THE GROWTH OF THIS SEGMENT 68
8.4 OTHER END USERS 70
9 MULTIMODAL IMAGING MARKET, BY REGION 72
9.1 INTRODUCTION 73
9.2 NORTH AMERICA 73
9.2.1 US 77
9.2.1.1 The US dominates the North American multimodal imaging market 77
9.2.2 CANADA 78
9.2.2.1 Government budget cuts and long wait time for scans to hamper the market growth 78
9.3 EUROPE 79
9.3.1 GERMANY 82
9.3.1.1 Favorable reimbursement scenario in the country to support market growth 82
?
9.3.2 UK 83
9.3.2.1 Government initiatives and the increasing number of funding and research activities related to the use of multimodal imaging are driving market growth 83
9.3.3 FRANCE 84
9.3.3.1 France has the third-largest government expenditure on healthcare—a major factor driving market growth 84
9.3.4 REST OF EUROPE 85
9.4 ASIA PACIFIC 86
9.4.1 JAPAN 90
9.4.1.1 Large installation base of hybrid imaging systems – a major factor driving market growth 90
9.4.2 CHINA 91
9.4.2.1 China to witness the highest growth rate in the global multimodal imaging market during the forecast period 91
9.4.3 INDIA 92
9.4.3.1 Lack of reimbursement for diagnostic imaging procedures to hamper market growth 92
9.4.4 REST OF ASIA PACIFIC 93
9.5 LATIN AMERICA 93
9.5.1 BRAZIL 96
9.5.1.1 Brazil dominates the Latin American multimodal imaging market due to the high burden of cancer 96
9.5.2 MEXICO 97
9.5.2.1 Rising incidence of cancer to drive market growth in Mexico 97
9.5.3 REST OF LATIN AMERICA 97
9.6 MIDDLE EAST & AFRICA 98
9.6.1 IMPROVED HEALTHCARE INFRASTRUCTURE AND GROWING AWARENESS OF MULTIMODAL IMAGING ARE DRIVING MARKET GROWTH IN THE MEA 98
10 COMPETITIVE LANDSCAPE 101
10.1 INTRODUCTION 101
10.2 MARKET SHARE ANALYSIS, 2018 102
10.3 COMPETITIVE SITUATION AND TRENDS 102
10.4 COMPETITIVE LEADERSHIP MAPPING 104
10.5 VENDOR INCLUSION CRITERIA 105
10.6 VENDOR DIVE 105
10.6.1 VISIONARY LEADERS 105
10.6.2 INNOVATORS 105
10.6.3 DYNAMIC DIFFERENTIATORS 105
10.6.4 EMERGING PLAYERS 105
?
11 COMPANY PROFILES 107
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 CANON, INC. 107
11.2 GE HEALTHCARE 110
11.3 HEIDELBERG ENGINEERING 113
11.4 INFRAREDX, INC. (A PART OF NIPRO CORPORATION) 114
11.5 KONINKLIJKE PHILIPS N.V. 116
11.6 MEDISO MEDICAL IMAGING SYSTEMS KFT 118
11.7 NEUSOFT MEDICAL SYSTEMS CO., LTD 119
11.8 SIEMENS HEALTHINEERS 121
11.9 SPECTRUM DYNAMICS MEDICAL 124
11.10 TOPCON CORPORATION 125
11.11 UNITED IMAGING HEALTHCARE CO., LTD. 127
11.12 ZEISS GROUP 129
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 131
12.1 DISCUSSION GUIDE 131
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
12.3 AVAILABLE CUSTOMIZATIONS 140
12.4 RELATED REPORTS 140
12.5 AUTHOR DETAILS 141
